All
Givinostat Wins U.S. FDA Fast Track Designation for Patients With PV
Treatment with givinostat has received fast track designation from the United States Food and Drug Administration for patients with polycythemia vera.
First Patient With Advanced Lung Cancer Dosed With Peluntamig Combo
The first patient was dosed in the SKYBRIDGE study assessing peluntamig with Tecentriq for advanced small cell lung cancer and neuroendocrine carcinomas.
Delving Into the Braftovi Plus Erbitux FDA Approval for BRAF+ mCRC
Dr. Cathy Eng discusses data that led to the FDA approval of Braftovi and Erbitux plus chemo for metastatic colorectal cancer with a BRAF V600E mutation.
A Staunch Advocate For Radiation Oncology Nursing and Compassionate Care
Everyone knows someone who has been affected by cancer.
A Personalized Approach to Bladder Preservation in Urologic Cancers
Bladder preservation for bladder cancer requires balancing clinical factors and patient health with a personalized treatment plan.
Mitigating Peripheral Neuropathy During Cancer Treatment
Dr. Shirley D'Sa discusses the importance of catching peripheral neuropathy in patients with Waldenström macroglobulinemia early on and how to treat it.
My Lung Cancer Journey: With Family, Friends and Medical Professionals
The strongest connections I’ve made are with others who have also been through their own cancer journeys.
AI Tool Predicts Pediatric Glioma Recurrence With Up to 89% Accuracy
An AI model using serial brain scans predicted glioma recurrence in children with up to 89% accuracy, outperforming single-image methods.
First-Line Keytruda Combo Elicits OS Results in Head and Neck Cancers
First-line treatment with a Keytruda combo had an overall survival of 17.6 months in some with recurrent/metastatic head and neck squamous cell carcinoma.
Cancer Survivor Raises AYA Awareness After Rare Lymphoma Diagnosis
In this Q&A, Carly Stafford Dixon discusses her lymphoma journey, recovery with CAR T therapy, and mission to raise support for young adults with cancer.
POIESIS Trial Explores Navtemadlin Plus Jakafi for Myelofibrosis
The phase 3 POIESIS trial is set to investigate navtemadlin as an add-on therapy to Jakafi in patients with JAK inhibitor-naive myelofibrosis.
An Expert Offers Advice and Resources for Navigating Rare Lymphoma
Dr. Neha Mehta-Shah shares how patients can better understand their subtype of rare lymphoma, as well as expands on the challenges these patients face.
Celebrating an Expert at Emotional Support
It is with great pride and admiration that I nominate Diane Hudson, RN, OCN, for the Extraordinary Healer Award for Oncology Nursing.
Dr. Eng Breaks Down Braftovi Plus Erbitux FDA Approval in BRAF+ mCRC
Dr. Cathy Eng discusses the importance of the Braftovi plus Erbitux FDA approval for treatment-naive BRAF V600E+ metastatic colorectal cancer.
A Healer’s Touch During My Experience With Cancer Care
The Calm of Unbroken Kindness
The nursing profession is home to countless extraordinary.
Breaking Down the Benefits of Clinical Trial Participation in Cancer Care
Dr. Scott T. Tagawa discusses what patients with prostate cancer should know about the potential benefits and risks of participating in a clinical trial.
Smoking Data May Guide Improved Lung Cancer Care and Patient Support
Most patients in accredited hospitals had smoking discussions documented, showing key care opportunities and smoking’s impact on treatment outcomes.
Renewal and Healing from Testicular Cancer This May
After testicular cancer, I’ve learned to guard my mood, seek small joys and embrace healing and renewal with every sunrise this spring.
First Patient Dosed With Azenosertib in Cyclin E1+ Ovarian Cancer
The first patient with Cyclin E1+ platinum-resistant ovarian cancer has been dosed with azenosertib in part 2a of the phase 2 DENALI clinical trial.
Pretreatment Baseline Screening for Breast Cancer-Related Lymphedema
New results from a breast cancer-related lymphedema study show the importance of measuring fluid and body composition before treatment begins.
Dosing of PAS-004 Begins in Patients in MAPK-Driven Tumors
Enrollment and initial dosing of PAS-004 at 30 milligrams has begun in three patients with MAPK pathway-driven advanced solid tumors.
Recapping Every FDA Approval Announced in April for Cancer Care
Here is a recap of every FDA approval announced by the regulatory agency in the month of April, spanning various cancer types.
Managing Fatigue During Breast Cancer Treatment: Tips for Conserving Energy
Breast cancer treatment is a physical, emotional, and mental challenge. Facing cancer and its side effects demands extraordinary physical, emotional, and spiritual stamina.
Breaking Down the Stigma and How to Better Understand Rare Blood Cancers
Dr. Neha Mehta-Shah discusses ways patients with rare blood cancers, such as lymphoma, can better understand their specific subtype of disease.
Triage Health Conference: Free Education to Navigate Health Care
Triage Health offers free, expert-led education on the legal and practical issues that impact individuals coping with chronic or serious medical conditions.
Advances in surgical techniques and targeted therapies for Pancreatic Cancer
Pancreatic cancer is one of the most challenging cancers to treat.
Endoscopic Procedure Removes GIST Without Surgery
A new endoscopic tunneling method, STER, allowed a patient to have a GIST removed without surgery, allowing quicker recovery and fewer complications.
Teddy Bears Are a Good Therapy for Adults With Cancer
Teddy bears offer emotional comfort and connection for adults with cancer, easing anxiety and fostering trust during treatment.
In Vivo CD19 CAR-T Leads to Remission in DLBCL Without Lymphodepletion
A patient with heavily pretreated relapsed/refractory diffuse large B-cell lymphoma achieved complete remission following novel in vivo CD19 CAR-T therapy.
